Journals / Selçuk Tıp Dergisi / 2010 / Cilt: 26 - Sayı: 1

Investigation of effect of acetylsalicylic acid on serum lipids

Asetilsalisilik asidin serum lipidleri üzerine olan etkilerinin araştırılması

Pages
5–8
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In conclusion, ASA treatment at 100 and 150 mg daily for a period of 2 months has no significant effect on blood lipid levels and further investigations about ASA treatment for longer time and at higher doses might be useful.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The aim of the study was to investigate the effect of 100 and 150 mg/day acetylsalicylic acid (ASA, aspirin) treatment on blood lipids.
📊
Key Findings & Data:The study group consisted of 30 healthy volunteers.
💡
Conclusion & Impact:In conclusion, ASA treatment at 100 and 150 mg daily for a period of 2 months has no significant effect on blood lipid levels and further investigations about ASA treatment for longer time and at higher doses might be useful.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

The aim of the study was to investigate the effect of 100 and 150 mg/day acetylsalicylic acid (ASA, aspirin) treatment on blood lipids. The study group consisted of 30 healthy volunteers. Of the volunteers, 17 (7F, 10M) received ASA as 100 mg (Group I) and 13 (5F, 8M) received ASA as 150 mg (Group II) daily for a period of two months. Fasting blood samples of the subjects were drawn before and 1 and 2 months after ASA treatment. Serum total cholesterol, high density lipoprotein (HDL) cholesterol and triglyceride levels of the subjects were measured by routine methods. Low-density lipoprotein (LDL) cholesterol levels were calculated by Friedwald formula. Althought total cholesterol, LDL cholesterol and triglyceride levels were slightly decreased and HDL cholesterol levels were slightly increased 2 months after ASA treatment in both groups, the differences between lipid levels were not statistically significant. In conclusion, ASA treatment at 100 and 150 mg daily for a period of 2 months has no significant effect on blood lipid levels and further investigations about ASA treatment for longer time and at higher doses might be useful.

Özet

Bu çalışmada, 100 ve 150 mg/gün Asetilsalisilik asid (ASA, aspirin) tedavisinin kan lipidleri üzerine etkisini araştırmayı amaçladık. Çalışmaya, toplam 30 sağlıklı gönüllü alındı. İki ay boyunca vakaların 17’si (7K, 10E) günde 100 mg (Grup I) ve 13’ü (5K, 8E) günde 150 mg (Group II) ASA kullandı. Vakaların ASA verilmeden önce ve verildikten 1 ve 2 ay sonra açlık kan örnekleri alındı. Bu kan örneklerinden serum total kolesterol, yüksek dansiteli lipoprotein (HDL) kolesterol, ve trigliserid seviyeleri rutin metodlarla ölçüldü. Düşük dansiteli lipoprotein (LDL) kolesterol seviyeleri Friedwald formülü kullanılarak hesaplandı. Her iki grup da 2 ay boyunca ASA tedavisi sonucu total kolesterol, LDL kolesterol ve trigliserid seviyelerinin biraz azaldığı, HDL kolesterol seviyelerinin ise biraz arttığı ancak bu değişikliklerin istatistiksel açıdan anlamlı olmadığı görüldü. Sonuç olarak günde 2 ay boyunca 100 ve 150 mg ASA tedavisinin kan lipidleri üzerine önemli bir etkisinin olmadığı ve bu konuda daha uzun süreli ve yüksek doz ASA tedavisinin araştırılmasının faydalı olacağı kanaatindeyiz.

🔖

Cite This Article

KURBAN, S., MEHMETOĞLU, İ., ERDEM, S. S. (2010). Investigation of effect of acetylsalicylic acid on serum lipids. Selçuk Tıp Dergisi, Cilt: 26 - Sayı: 1, 5–8. https://ajindex.com/articles/319279

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (15)

  1. Awtry EH, Loscalzo J. Aspirin. Circulation 2000; 101: 1206-18
  2. Hennekens CH. Update on aspirin in the treatment and prevention of cardiovascular disease. Am J Manag Care 2002; 8: 691-700
  3. Smith JB, Araki H, Lefer AM. Thromboxane A2, prostacyclin and aspirin: effects on vascular tone and platelet aggregation. Circulation 1980; 62: 19- 25
  4. Patrono C, Coller B, Dalen JE, et al. Platelet-active drugs: the relationships among dose, effectiveness, and side effects. Chest 1998; 114: 470-88
  5. Wu R, Lamontagne D, de Champlain J. Antioxidative properties of acetylsalicylic Acid on vascular tissues from normotensive and spontaneously hypertensive rats. Circulation 2002; 105: 387-92
  6. Dhalla NS, Temsah RM, Netticadan T. Role of oxidative stress in cardiovascular diseases. J Hypertens 2000; 18: 655-73
  7. Verhoye E, Langlois MR, Rietzchel E, et al. Asklepios Investigators. Circulating oxidized low-density lipoprotein: a biomarker of atherosclerosis and cardiovascular risk? Clin Chem Lab Med 2009; 47: 128-37
  8. Cyrus T, Yao Y, Tung LX, et al. Stabilization of advanced atherosclerosis in low-density lipoprotein receptor-deficient mice by aspirin. Atherosclerosis 2006; 184: 8-14
  9. Kurban S, Mehmetoglu I. Effects of acetylsalicylic acid on serum paraoxonase activity, Ox-LDL, coenzyme Q(10) and other oxidative stress markers in healthy volunteers. Clin Biochem. 2009. 10.1016/j.clinbiochem2 009.10.054
  10. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999; 340: 115–26
  11. Costanzo A, Moretti F, Burgio VL, et al. Endothelial activation by angiotensin II through NFkappaB and p38 pathways: Involvement of NFkappaBinducible kinase (NIK), free oxygen radicals, and selective inhibition by aspirin. J Cell Physiol 2003; 195: 402-10
  12. Tauseef M, Shahid M, Sharma KK, et al. Antioxidative action of aspirin on endothelial function in hypercholesterolaemic rats. Basic Clin Pharmacol Toxicol 2008; 103: 314-21
  13. Podhaisky HP, Abate A, Polte T, et al. Aspirin protects endothelial cells from oxidative stress--possible synergism with vitamin E. FEBS Lett 1997; 417: 349-51
  14. Nobukuni Y, Higashikawa F, Miyagawa K, Eboshida A. Hyperlipidemia: complex pathophysiology caused by multiple genetic and environmental factors--in considering the approaches to preventive medicine Nippon Eiseigaku Zasshi. 2005; 60: 426-441
  15. Gould AL, Davies GM, Alemao E, et al. Cholesterol reduction yields clinical benefits: meta-analysis including recent trials. Clin Ther